Latest Asx Listing Rules News

Regener8 Resources has addressed a sharp doubling in its share price, attributing the surge to growing market interest in its North Achilles project amid soaring silver prices and nearby discoveries.

Superior Resources Limited clarifies recent share price jump, attributing it to soaring gold prices and imminent resource updates, while confirming no undisclosed information.

VHM Limited has clarified that a non-binding US$200 million letter of interest from the US Export-Import Bank for its Goschen project is not material to its share price, confirming full compliance with ASX disclosure rules despite recent market speculation.

Invion Limited has secured $0.8 million through convertible notes to repay its Lind Global Fund II LP facility and support working capital, positioning itself for potential global licensing deals of its Photosoft technology.

Kingsgate Consolidated updates its 2025 Mineral Resources and Ore Reserves, introducing a maiden estimate for the Chatree South-East Complex while reporting modest declines in overall Ore Reserves.

Findi Limited has responded to ASX inquiries about unusual stock price and volume movements, denying any undisclosed information and announcing legal action against a former subsidiary executive for misleading social media posts.

Carawine Resources Limited’s shares have been suspended from trading following a Federal Court ruling that allows QGold Pty Ltd to compulsorily acquire all remaining shares it does not own.

Nordic Resources Ltd attributes its recent share price and volume spike to a successful investor roadshow and capital raising tied to its new Finland gold projects, while confirming full ASX compliance.

Discovery Alaska Limited has detailed its exploration expenditures and strategic pivot from Alaskan projects to new US acquisitions, affirming its financial health and operational sufficiency to maintain its ASX listing.

Wellard Limited has formally requested to delist from the ASX following the sale of its final revenue-generating vessel, aiming to reduce costs and return excess cash to shareholders. The move awaits shareholder approval at the upcoming AGM.

EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.

Austral Resources Australia Limited has extended the closing date for its $40 million placement offer to 20 October 2025, alongside an ASX suspension extension to 31 October to meet reinstatement conditions.